Pharmacological targeting of MTHFD2 suppresses NSCLC via the regulation of ILK signaling pathway.
Zhou F, Yuan Z, Gong Y, Li L, Wang Y, Wang X, Ma C, Yang L, Liu Z, Wang L, Zhao H, Zhao C, Huang X.
Zhou F, et al. Among authors: wang x, wang l, wang y.
Biomed Pharmacother. 2023 May;161:114412. doi: 10.1016/j.biopha.2023.114412. Epub 2023 Feb 22.
Biomed Pharmacother. 2023.
PMID: 36827714
Free article.